New prognostic test for breast cancer could improve patient treatment
3/12/2014
A study by researchers in Nottingham has developed a new clinical test for breast cancer which aims to improve patient treatment.The Nottingham Prognostic Index Plus (NPI+) could be available to patients within two years.
Worldwide standard in diagnosing melanoma pioneered by Moffitt Cancer Center
3/12/2014
Moffitt Cancer Center researchers have been instrumental in making significant improvements to the diagnostic procedure called sentinel node biopsy for melanoma patients and teaching this procedure to physicians from around the world.Sentinel nodes are the first lymph nodes to which cancer cells from a primary tumor like melanoma will spread.
Promising treatment for stubborn blood cancers
3/12/2014
A pill that suppresses a key regulator of cancer growth may provide hope to relapsed leukemia and lymphoma patients running out of treatment options for their aggressive, treatment-resistant disease, according to three reports* published online in Blood, the journal of the American Society of Hematology.
Potent driver of metastasis identified
3/12/2014
Protein Correlates with Breast, Bladder, Melanoma, and Thyroid TumorsAn international team of researchers led by scientists at The Wistar Institute have discovered and defined LIMD2, a protein that can drive metastasis, the process where tumors spread throughout the body.
After joint replacement surgery, statins may lower blood clot risk
3/12/2014
Statins have long been known to lower cholesterol and, more recently, to decrease the risk of deep vein thrombosis (blood clots) in healthy, non-surgical patients.
Convenient, less expensive, but possibly riskier new prostate cancer treatment: SBRT
3/12/2014
A faster and less expensive form of radiotherapy for treating prostate cancer may come at a price, according to a new study by Yale School of Medicine researchers - a higher rate of urinary complications.The standard external beam radiation therapy for prostate cancer is called intensity modulated radiation therapy (IMRT).
Risk of prostate cancer death decreased by PSA-testing and early treatment
3/12/2014
Mortality in prostate cancer is lower in areas with frequent use of PSA testing compared with areas with little testing shows a study published online in Journal of the National Cancer Institute by researchers from Umeå University, Sweden and Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Glycoprofiling provides new sugar-test to reduce false-positive cancer diagnoses
3/12/2014
The world's most widespread test for ovarian cancer reports false-positives in 94 of 100 diagnosed cases. Now, chemists at the University of Copenhagen working with clinical researchers at University College London have developed a method able to halve the number of false-positives.
Increased risk of cancer later in life for young skin cancer survivors
3/12/2014
Young people who have been diagnosed with non-melanoma skin cancer (NMSC) related to sun exposure, under the age of 25, face a higher risk of developing melanoma and other cancers later in life, a UK study has shown.
Why knowing about the negative health impacts of tobacco does not prevent smokers from lighting up
3/12/2014
What if the use of a product influenced your perception of it, making you even more susceptible to its positive aspects and altering your understanding of its drawbacks? This is precisely what happens with cigarettes in chronic smokers, according to a recent study by the Institut universitaire en sante mentale de Montreal and Universite de Montreal.